Trial intelligence / Profile preview

Acetyl-L-Carnitine Supplementation in HCV Therapy

NCT01913964Phase 4Completed

Sponsor
University of Catania
Start
Oct 1997
Primary completion
Oct 1997
Modality
Small Molecules
01

Overview

A Phase 4 trial of acetyl-l-carnitine in hepatitis C (HCV), sponsored by University of Catania. Started Oct 1997; status: completed.

02

Drugs

acetyl-l-carnitine
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT01913964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01913964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call